Related Experiment Video
Updated: Aug 9, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Published on: May 1, 2015
Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancer
Mariana Dunn1, Prakash Sinha, Rebecca Campbell
1Cancer Biology Laboratory, Research School of Biosciences, University of Kent, Canterbury, UK.
Abstract:
We have produced antibodies to the NRG2-alpha, NRG2-beta, NRG3 and NRG4 proteins and used these, and previously described antibodies to NRG1-alpha and NRG1-beta, to detect expression of each ligand by immunocytochemical staining in a series of 45 breast cancers. Each protein was expressed in a proportion of cases. Statistical analysis suggested that expression of one factor was associated with a high probability that other members of the family were co-expressed. NRG2-alpha expression was associated with node positivity (p-value = 0.005). The mRNAs for NRG1, 2, 3 and 4 were found in established breast cancer cell lines and NRG1, 2 and 3 mRNAs were detected in primary breast cancers. Expression of NRG4 mRNA was shown by in situ hybridization in sections from primary breast cancers. This data demonstrates that each member of the NRG family of ligands is expressed in breast cancer and suggests that they may be involved in regulating cell behaviour.
Insights
The Neuregulin (NRG) family of ligands is expressed in breast cancer. NRG2-alpha expression correlates with lymph node positivity, suggesting a role in breast cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The Neuregulin (NRG) family of proteins plays crucial roles in cell growth, differentiation, and survival.
- Aberrant NRG signaling is implicated in various cancers, including breast cancer.
Purpose of the Study:
- To investigate the expression patterns of all four Neuregulin (NRG) family members (NRG1-4) in human breast cancer tissues.
- To determine potential correlations between NRG expression and clinical parameters, such as lymph node status.
Main Methods:
- Production of specific antibodies for NRG2-alpha, NRG2-beta, NRG3, and NRG4.
- Immunocytochemical staining of 45 breast cancer samples to detect NRG protein expression.
- Analysis of NRG mRNA expression in breast cancer cell lines and primary tumors using RT-PCR and in situ hybridization.
Main Results:
- All four NRG ligands (NRG1-4) were detected in breast cancer samples, with varying proportions of expression.
- Statistical analysis indicated a tendency for co-expression among different NRG family members.
- NRG2-alpha expression was significantly associated with lymph node positivity (p=0.005).
- NRG mRNAs were detected in breast cancer cell lines and primary tumors, with NRG4 mRNA localization confirmed by in situ hybridization.
Conclusions:
- Each member of the Neuregulin (NRG) ligand family is expressed in breast cancer.
- The findings suggest that NRG family members may be involved in regulating breast cancer cell behavior and progression.
- NRG2-alpha expression may serve as a potential biomarker for disease spread.
Related Concept Videos
The Nucleolus
Mitogens and the Cell Cycle
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

